PM
CLVS

Prosight Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Prosight Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
2019
Q3 		$2.31M Buy
2019
Q2 		$6.69M Buy
2019
Q1 		$6.19M Buy
2018
Q4 		$1.08M Buy
2018
Q2 		– Sell
2018
Q1 		$2.43M Buy
2017
Q4 		$2.72M Buy